Alphinity designs and manufactures next-generation single-use bioprocessing equipment for the modalities conventional hardware quietly fails. As therapies have grown more fragile and more valuable, from viral vectors and lipid nanoparticles to cell and gene therapies, mRNA and antibody-drug conjugates, the pumps, valves and filtration they rely on have largely stood still. Alphinity closes that gap, engineering equipment that protects the molecule rather than punishing it, so more of every batch reaches the patient. Our purpose is to enable abundance in medicine.

The advantage is engineered, not assembled. Because we build the underlying pump, valve and control technology ourselves, our systems remove the shear, cavitation and imprecise control that quietly degrade sensitive products.

TFFi, our single-use TFF system and winner of the Interphex 2026 Best Technology Innovation Award, delivers low shear and high recovery from 30 mL to 10 L, handling higher pressure, flow and more viscous material at once, and transfers seamlessly from process development to manufacturing on one architecture. It runs on our gravity-flooded PIXER pump and fully electric VannX and ARTēVA valves.

Running on the ProCaaSo® platform from sister company ConSynSys, an Alphinity system becomes a fully automated, walk-away process with precise closed-loop control and automatic batch records. And through our
Prove-It program, we run a customer’s own process on TFFi, head to head with their existing equipment, on their material and their data.

Learn more at alphinity.io or contact info@alphinity.io.